Clinical Trial Update: Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the combination of docetaxel, cisplatin, and 5-fluorouracil for locally advanced head and neck squamous cell carcinoma; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Advanced Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck | Phase 1, Phase 2 | Status: COMPLETED